Relative potencies of dipyridamole and related agents as inhibitors of cyclic nucleotide phosphodiesterases: Possible explanation of mechanism of inhibition of platelet function
Authors:
- Frances A. McElroyFMFrances A. McElroy
- Richard B. PhilpRPRichard B. Philp
- 1 November 1975
- journal article
- Published by Elsevier in Life Sciences
- Vol. 17 (9) , 1479-1493
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Effects of collagen and of aspirin on the concentration of guanosine 3′:5′-cyclic monophosphate in human blood platelets: measurement by a prelabelling technique (Short Communication)Biochemical Journal, 1974
- Multiple forms of cyclic adenosine 3′,5′-monophosphate phosphodiesterase from human blood platelets. I. Kinetic and electrophoretic characterization of two molecular speciesBiochimica et Biophysica Acta (BBA) - Enzymology, 1973
- Effects of dipyridamole and five related agents on human platelet aggregation and adenosine uptakeThrombosis Research, 1973
- Studies with phophodiesterase. III. Two forms of the enzyme from human blood plateletsBiochimica et Biophysica Acta (BBA) - Enzymology, 1973
- The Effect of Pyrimidine Compounds on the Potentiation of Adenosine Inhibition of Aggregation, on Adenosine Phosphorylation and Phosphodiesterase Activity of Blood PlateletsBritish Journal of Haematology, 1973
- Platelet and Fibrinogen Consumption in ManNew England Journal of Medicine, 1972
- Assessment of antithrombotic agents: effects of dipyridamole analogues on platelet behaviourCardiovascular Research, 1972
- Effect in vitro on platelet function of two compounds developed from the pyrimido-pyrimidinesJournal of Clinical Pathology, 1972
- A simple and sensitive saturation assay method for the measurement of adenosine 3′:5′-cyclic monophosphateBiochemical Journal, 1971
- Cyclic 3′,5′-adenosine monophosphate in human blood plateletsJournal of Clinical Investigation, 1971